Fig. 6: Solicited symptoms through 7 days after each intranasal vaccination. | Nature Communications

Fig. 6: Solicited symptoms through 7 days after each intranasal vaccination.

From: An intranasal adjuvanted, recombinant influenza A/H5 vaccine primes against diverse H5N1 clades: a phase I trial

Fig. 6

All solicited events were mild or moderate. No reports of nosebleed, hearing difficulty, double vision, joint pain, ear ringing, slurred speech, eye swelling, chest tightness, or wheezing. Figure colors: immediate mild (light gray), immediate moderate (black), 7-day mild (pink), 7-day moderate (red).

Back to article page